Aesica partners with Durham and Leeds Universities for new manufacturing technology
Aesica Pharmaceuticals could soon benefit from improved API manufacturing processes thanks to a partnership with experts at the Universities of Durham and Leeds.
Aesica Pharmaceuticals has announced a partnership with the Universities of Durham and Leeds to bring new API manufacturing technologies to market.
The announcement follows the recent annual Genesis conference and is Aesica's second major innovation board partnership since the event.
The new partnership will aim to develop new or improved methods for the manufacture of APIs at the global contract manufacturing organisation's Cramlington plant.
It is hoped that by identifying alternative technologies, it may be possible to improve cost-efficiencies and increase manufacturing capacity at the facility.
The work will be funded by a METRC Innovation Grant, according to Professor Steve Armes, academic director of METRC.
He confirmed: "Alternative manufacturing processes will be investigated to increase the manufacturing capacity of the API, as well as exploring how to achieve cost efficiencies at the Aesica Cramlington manufacturing site."
Barrie Rhodes, director of technology development at Aesica Pharmaceuticals, said he was "delighted" to embark on the partnership with Durham's Professor Andrew Whiting and Leeds' Professor Frans Muller "to bring together the best that industry and academia have to offer, in the interests of pharmaceutical innovation".
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance